Details for New Drug Application (NDA): 009766
✉ Email this page to a colleague
NDA 009766 describes METICORTEN, which is a drug marketed by Schering and is included in one NDA. Additional details are available on the METICORTEN profile page.
The generic ingredient in METICORTEN is prednisone. There are sixteen drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the prednisone profile page.
The generic ingredient in METICORTEN is prednisone. There are sixteen drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the prednisone profile page.
Summary for 009766
| Tradename: | METICORTEN |
| Applicant: | Schering |
| Ingredient: | prednisone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 009766
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
